JAMES S BALDASSARRE
Medical Practice in Gardenville, PA
License number
Pennsylvania MD039638E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Gardenville, PA 18901
Personal information
See more information about JAMES S BALDASSARRE at radaris.comName
Address
Phone
145 Pebble Woods Dr, Doylestown, PA 18901
148 Kings Ct, Henryville, PA 18332
Doylestown, PA
16 Young Oak Ct, Henryville, PA 18332
431 Dartmouth Ct, Bensalem, PA 19020
Professional information
Methods Of Treating Term And Near-Term Neonates Having Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension
US Patent:
2010033, Dec 30, 2010
Filed:
Jun 22, 2010
Appl. No.:
12/820980
Inventors:
James S. Baldassarre - Doylestown PA, US
Ralf Rosskamp - Chester NJ, US
Ralf Rosskamp - Chester NJ, US
Assignee:
Ikaria Holdings, Inc. - Clinton NJ
International Classification:
A61K 33/00, A61K 31/04, A61P 9/10, A61P 9/12, A61M 1/12
US Classification:
424600, 514742, 600 18
Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
Methods Of Treating Term And Near-Term Neonates Having Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension
US Patent:
2010033, Dec 30, 2010
Filed:
Jun 22, 2010
Appl. No.:
12/820866
Inventors:
James S. Baldassarre - Doylestown PA, US
Ralf Rosskamp - Chester NJ, US
Ralf Rosskamp - Chester NJ, US
Assignee:
Ikaria Holdings, Inc. - Clinton NJ
International Classification:
A61K 33/00, A61P 9/10, A61P 9/12, A61M 1/10
US Classification:
424718, 600 18
Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
Methods Of Reducing The Risk Of Occurrence Of Pulmonary Edema In Children In Need Of Treatment With Inhaled Nitric Oxide
US Patent:
8282966, Oct 9, 2012
Filed:
Jun 22, 2010
Appl. No.:
12/821020
Inventors:
James S. Baldassarre - Doylestown PA, US
Ralf Rosskamp - Chester NJ, US
Ralf Rosskamp - Chester NJ, US
Assignee:
INO Therapeutics LLC - Hampton NJ
International Classification:
A01N 59/00, A61K 33/00, C01B 21/24, A61M 16/00
US Classification:
424718, 12820024, 423405
Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
Methods Of Reducing The Risk Of Occurrence Of Pulmonary Edema In Term Or Near-Term Neonates In Need Of Treatment With Inhaled Nitric Oxide
US Patent:
8293284, Oct 23, 2012
Filed:
Jun 22, 2010
Appl. No.:
12/821041
Inventors:
James S. Baldassarre - Doylestown PA, US
Ralf Rosskamp - Chester NJ, US
Ralf Rosskamp - Chester NJ, US
Assignee:
INO Therapeutics LLC - Hampton NJ
International Classification:
A01N 59/00, A61K 33/00, C01B 21/24, A61M 16/00
US Classification:
424718, 12820024, 423405
Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.